Our news

• NovaMedica team in the TOP 100 INFLUENTIAL PEOPLE IN THE PHARMACEUTICAL BUSINESS 2024

  28 November 2024

  

  The team of top managers of NovaMedica was highly appraised for our contribution to the development of the pharmaceutical industry.

• Leading Experts on Migraine and Headache Therapy Will Present the Results of the Multicenter Post-Registration Observational Study “EXPERIENCE” on the Use of Rizatriptan in Patients at the 15th Manage Pain Congress Launched in Moscow

  05 November 2024

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  On November 5, 2024, the anniversary 15^th Manage Pain Congress opened in Moscow. NovaMedica is supporting one of the most important interdisciplinary events for the medical community aimed at exchanging advanced knowledge and experience in organizing care and treatment for patients suffering from various pain syndromes.

• Double Strike: Experts, with the Support of NovaMedica, Discuss New Opportunities for the Treatment of Sleep Disorders at the 2nd All-Russian Neurocongress

  03 November 2024

  

  ONLY FOR HEALTHCARE PROFESSIONALS

  Providing Russian patients with innovative drugs for the treatment of psychiatric and neurological disorders is a priority for NovaMedica (an investment project of Rusnano). The company’s development strategy is based on building up competencies in the development of unique drugs and organizing their production at the NovaMedica Innotech technology center.

• October 10 – World Mental Health Day

  10 October 2024

  

  World Mental Health Day is a great opportunity to thank doctors – neurologists, psychiatrists, psychotherapists, narcologists, geriatricians and all those who pay great attention to mental health – for their daily work with patients and their desire to help everyone, for their high professionalism and constant improvement of their knowledge and skills.

• Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference

  10 October 2024

  

  Marketing Director of NovaMedica Liliya SAVELYEVA shared with colleagues the practical experience accumulated by our team in the field of implementing analytical tools using data from the drug flow monitoring (DFM) system at the International conference “What is Happening in the Pharmaceutical Market?”

• NovaMedica in the TOP-1000 Russian Managers Rating

  28 September 2024

  

  The TOP-1000 Russian Managers rating is an annual project of the Managers Association promoting the highest management standards. This year, it is being held for the 25^th time. It recognizes the “best of the best” among managers and records trends in the upper and functional echelons of Russian business. The leaders of NovaMedica have been included in this prestigious list since 2016. This year, NovaMedica once again received high assessment from the expert community: Oksana KRASNYKH, Head of the Business Division of NovaMedica, made it to the top 100 commercial directors of Russia for the second time.

• NovaMedica spoke on its experience in improving quality systems of pharmaceutical enterprises at the 9th All-Russian GMP Conference

  06 September 2024

  

  The 9th All-Russian GMP Conference was held in Ufa on August 21-23. It was named as the biggest event of the pharmaceutical industry in the field of developing good manufacturing practices. NovaMedica experts shared their experience in managing data integrity, which was highly appreciated by the participants for its relevance and practical value.

• NovaMedica expands its line of products for the treatment of Alzheimer’s disease

  22 August 2024

  

  Russian pharmaceutical company NovaMedica (RUSNANO portfolio company) has added Alzer^®-H^[1]  (INN Donepezil) for the treatment of dementia associated with Alzheimer’s disease to its portfolio. Combination of the new product with NovaMedica’s other complementary drugs will allow Russian doctors to provide modern therapy at various stages of the disease and will increase availability of effective treatment for Russian patients.

• Children visited the NovaMedica Innotech pharmaceutical manufacturing facility

  14 June 2024

  

  On June 7, 2024, the NovaMedica Innotech manufacturing site located in Technopolis Moscow held an educational tour for children “The Birth of a Medicine from A to Z” to celebrate the International Children’s Day.

• NovaMedica is expanding its portfolio of drugs for the treatment of diseases of the central nervous system

  16 May 2024

  

  A new drug from the Russian pharmaceutical company NovaMedica (portfolio company of Rusnano) for the treatment of cerebrovascular disorders DIEZO^® 500^[1] (INN Citicoline) in solid dosage form has successfully passed state registration in the Russian Federation in accordance with the requirements of the EAEU.